The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years

BACKGROUND: Data on Human Papilloma virus (HPV) vaccine immune response in sub-Saharan Africa is still sparse yet such knowledge is critical for optimal implementation and monitoring of HPV vaccines. Our primary objective was to evaluate levels of anti-HPV-16/18 antibodies and six other ‘high risk’...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakalembe, Miriam, Banura, Cecily, Namujju, Proscovia B, Mirembe, Florence M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158334/
https://www.ncbi.nlm.nih.gov/pubmed/25206925
http://dx.doi.org/10.1186/1750-9378-9-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158334/
https://www.ncbi.nlm.nih.gov/pubmed/25206925
http://dx.doi.org/10.1186/1750-9378-9-29

Ejemplares similares